Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 8 clinical trials
featured
A Phase IIIb Multi-Center, Open-Label, Mirror-Image, Trial in Adult Subjects with Schizophrenia Treated Prospectively for 6-months with Abilify MyCite®

(Months 1 to 3) while subjects are on oral standard-of-care antipsychotic treatment and the prospective period (Months 1 to 3) after the subjects switch to Abilify MyCite®.

  • 32 views
  • 23 Nov, 2020
  • 1 location
Propranolol for Challenging Behaviors in Autism

only two medications (Risperdal and Abilify) rigorously studied and FDA-approved for the treatment of irritability in individuals with ASD. These medications are not always successful and have many

propranolol
antipsychotics
autism
abilify
psychotropic drugs
  • 7 views
  • 22 Mar, 2021
  • 1 location
DNA Diagnostics for Minimizing Metabolic Side-Effects of Antipsychotics

The purpose of this study is to assess patients treated with the antipsychotics aripiprazole (Abilify®), olanzapine (Zyprexa®), quetiapine (Seroquel®), risperidone (Risperdal®), or

ziprasidone
zyprexa
aripiprazole
quetiapine
antipsychotics
  • 202 views
  • 07 Nov, 2020
  • 2 locations
Specified Drug-use Survey on Abilify Prolonged Release Aqueous Suspension for IM Injection (Prevention of Relapse of Mood Episodes in BP)

To investigate the safety for an observation period of 52 weeks with use of Abilify prolonged release aqueous suspension for intramuscular (IM) injection in patients with bipolar I disorder for

  • 0 views
  • 12 May, 2021
  • 1 location
Abilify Maintena PMS in Schizophrenia Patients or Bipolar 1 Disorder

This is a Post-Marketing Surveillance (PMS) of Abilify Maintena Injections in accordance with Korean regulations on New Drug Re-examination (i.e. New Drug Re-examination Standards: Ministry of

bipolar disorder
abilify
schizophrenia
  • 1 views
  • 23 Jan, 2021
  • 1 location
Observational Study of Long Acting Injectable Medications (LAIs) in Schizophrenia (OASIS)

Injectable (LAI) antipsychotics (ABILIFY MAINTENA, ARISTADA, INVEGA SUSTENNA or RISPERDAL CONSTA)

risperdal
antipsychotics
abilify
  • 109 views
  • 11 May, 2021
  • 51 locations
National Pregnancy Registry for Atypical Antipsychotics

The purpose of the National Pregnancy Registry for Atypical Antipsychotics is to determine the frequency of birth defects among infants exposed to atypical antipsychotics.

antipsychotics
atypical antipsychotic
typical antipsychotic
  • 352 views
  • 08 Sep, 2021
  • 1 location
Effect on Metabolic Parameters of Abilify in SPR

To measure the long-term changes in weight and plasma lipids after switching antipsychotic treatment to aripiprazole

aripiprazole
antipsychotics
abilify
  • 6 views
  • 07 Nov, 2020
  • 1 location